Propiedad y actividad de insiders de Karyopharm Therapeutics Inc. (KPTI): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $1.70 |
| Capitalización | $39M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-09-01 | Abate Kristin | S-Sale | 19 | $38 |
| 2026-07-28 | Poulton Stuart | S-Sale | 189 | $1K |
| 2026-05-21 | Oliger Christy J. | A-Award | 15,508 | |
| 2026-05-21 | PAKIANATHAN DEEPIKA | A-Award | 15,508 | |
| 2026-05-21 | Schor Chen | A-Award | 15,508 | |
| 2026-05-21 | Su Zhen | A-Award | 15,508 | |
| 2026-05-21 | BOHLIN GAREN G | A-Award | 15,508 | |
| 2026-05-21 | Greene Barry E | A-Award | 15,508 | |
| 2026-05-13 | Poulton Stuart | A-Award | 896 | |
| 2026-05-14 | Poulton Stuart | S-Sale | 403 | $4K |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $49.7M | $69.0M | $118.0M | $128.9M | $85.9M | $190.5M | $135.2M | $52.2M | $62.5M | $60.5M |
| Inversiones a Corto | $79.9M | $77.5M | $210.2M | $133.1M | $163.3M | $38.2M | $142.8M | $139.2M | $46.2M | $3.2M |
| Cuentas por Cobrar | 0 | 0 | 0 | $7.9M | $12.9M | $22.5M | $47.1M | $27.0M | $30.8M | $26.2M |
| Inventario | 0 | 0 | 0 | $346000 | $2.6M | $4.1M | $4.2M | $3.0M | $4.7M | $4.0M |
| Activos Corrientes | $131.6M | $148.4M | $334.6M | $278.6M | $276.5M | $275.6M | $350.2M | $233.9M | $156.5M | $103.1M |
| Inmovilizado Material | $2.8M | $2.2M | $3.9M | $13.7M | $11.6M | $9.6M | $7.4M | $4.9M | $6.3M | $4.7M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $180.4M | $180.3M | $341.2M | $295.0M | $313.1M | $305.3M | $358.2M | $240.4M | $164.4M | $108.4M |
| Cuentas por Pagar | $4.8M | $5.7M | $4.3M | $985000 | $4.5M | $1.6M | $2.8M | $3.1M | $5.1M | $4.0M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $24.4M | $21.0M |
| Pasivos Corrientes | $16.5M | $49.5M | $46.9M | $46.4M | $60.2M | $73.7M | $65.9M | $69.5M | $92.3M | $92.1M |
| Deuda a Largo | 0 | 0 | $102.7M | $109.9M | $117.9M | $169.3M | $170.1M | $170.9M | $162.9M | $205.9M |
| Pasivos Totales | $18.1M | $50.8M | $158.0M | $245.2M | $262.5M | $385.0M | $374.8M | $376.6M | $350.4M | $401.3M |
| Reservas | -$366.1M | -$495.3M | -$673.7M | -$873.3M | -$1.07B | -$1.18B | -$1.34B | -$1.49B | -$1.56B | -$1.76B |
| Patrimonio Neto | $162.2M | $129.5M | $183.2M | $49.8M | $50.5M | -$79.7M | -$16.7M | -$136.2M | -$186.0M | -$292.9M |
| Deuda Total | 0 | 0 | $102.7M | $124.7M | $131.1M | $180.6M | $179.1M | $177.0M | $194.5M | $233.6M |
| Deuda Neta | -$129.6M | -$146.5M | -$225.5M | -$137.3M | -$118.1M | -$48.0M | -$98.9M | -$14.4M | $85.8M | $169.9M |
| Capital Circulante | $115.2M | $99.0M | $287.7M | $232.2M | $216.3M | $201.9M | $284.3M | $164.4M | $64.2M | $11.1M |
Salud financiera
| Deuda / Patrimonio | -0.65 |
| Ratio corriente | 0.79 |
Rentabilidad
| Rentabilidad sobre capital | 77.63% |
| Rentabilidad sobre capital invertido | 376.87% |
| Rentabilidad sobre activos | -201.89% |
| Margen bruto | 95.88% |
| Margen operativo | -56.17% |
| Margen neto | -153.28% |
Empresas relacionadas: ALGS · BRNS · CVM · FGEN · INMB · MDCX · MRSN
Explorar sector: Healthcare · Biotechnology
Más secciones de KPTI: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones